200 related articles for article (PubMed ID: 25720573)
21. Prognostic impact of the mean platelet volume/platelet count ratio in terms of survival in advanced non-small cell lung cancer.
Inagaki N; Kibata K; Tamaki T; Shimizu T; Nomura S
Lung Cancer; 2014 Jan; 83(1):97-101. PubMed ID: 24189108
[TBL] [Abstract][Full Text] [Related]
22. Prognostic index score predicts outcome of patients with Stage I non-small cell lung cancer after stereotactic body radiation therapy.
Shi S; Ye L; Zhao Q; Hu Y; Huang Y; Chen G; Zeng Z; He J
Jpn J Clin Oncol; 2019 Apr; 49(4):367-372. PubMed ID: 30715411
[TBL] [Abstract][Full Text] [Related]
23. Are neutrophil/lymphocyte ratio and platelet/lymphocyte ratio associated with prognosis in patients with HER2-positive early breast cancer receiving adjuvant trastuzumab?
Ulas A; Avci N; Kos T; Cubukcu E; Olmez OF; Bulut N; Degirmenci M
J BUON; 2015; 20(3):714-22. PubMed ID: 26214622
[TBL] [Abstract][Full Text] [Related]
24. Initial neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as prognostic markers in patients with inoperable locally advanced non-small-cell lung cancer.
Sun S; Qu Y; Wen F; Yu H
Biomark Med; 2020 Oct; 14(14):1341-1352. PubMed ID: 32808809
[No Abstract] [Full Text] [Related]
25. Systemic immune-inflammation index (SII) is useful to predict survival outcomes in patients with surgically resected non-small cell lung cancer.
Guo W; Cai S; Zhang F; Shao F; Zhang G; Zhou Y; Zhao L; Tan F; Gao S; He J
Thorac Cancer; 2019 Apr; 10(4):761-768. PubMed ID: 30734516
[TBL] [Abstract][Full Text] [Related]
26. Elevated platelet count is a strong predictor of poor prognosis in stage I non-small cell lung cancer patients.
Ji Y; Sheng L; Du X; Qiu G; Su D
Platelets; 2015; 26(2):138-42. PubMed ID: 24679181
[TBL] [Abstract][Full Text] [Related]
27. [Meta-analysis of Platelet Lymphocyte Ratio as A Prognostic Factor for
Non-small Cell Lung Cancer].
Chen H; Xue H; Liu W; Wu F; Wang Y; Gao H
Zhongguo Fei Ai Za Zhi; 2019 May; 22(5):289-298. PubMed ID: 31109438
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of preoperative hematologic markers as prognostic factors and establishment of novel risk stratification in resected pN0 non-small-cell lung cancer.
Zhang T; Jiang Y; Qu X; Shen H; Liu Q; Du J
PLoS One; 2014; 9(10):e111494. PubMed ID: 25360716
[TBL] [Abstract][Full Text] [Related]
29. Role of increased mean platelet volume (MPV) and decreased MPV/platelet count ratio as poor prognostic factors in lung cancer.
Omar M; Tanriverdi O; Cokmert S; Oktay E; Yersal O; Pilancı KN; Menekse S; Kocar M; Sen CA; Ordu C; Goksel G; Meydan N; Barutca S;
Clin Respir J; 2018 Mar; 12(3):922-929. PubMed ID: 28026133
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value of platelet count and lymphocyte to monocyte ratio combination in stage IV non-small cell lung cancer with malignant pleural effusion.
Lim JU; Yeo CD; Kang HS; Park CK; Kim JS; Kim JW; Kim SJ; Lee SH
PLoS One; 2018; 13(7):e0200341. PubMed ID: 30005083
[TBL] [Abstract][Full Text] [Related]
31. Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio are Predictors of Heart Failure.
Durmus E; Kivrak T; Gerin F; Sunbul M; Sari I; Erdogan O
Arq Bras Cardiol; 2015 Dec; 105(6):606-13. PubMed ID: 26536980
[TBL] [Abstract][Full Text] [Related]
32. Preoperative pulmonary function correlates with systemic inflammatory response and prognosis in patients with non-small cell lung cancer: results of a single-institution retrospective study.
Gao Y; Zhang H; Li Y; Wang D; Ma Y; Chen Q
Oncotarget; 2017 Apr; 8(16):27489-27501. PubMed ID: 28039482
[TBL] [Abstract][Full Text] [Related]
33. A prognostic parameter in advanced non-small cell lung cancer: the ratio of hemoglobin-to-red cell distribution width.
Bozkaya Y; Kurt B; Gürler F
Int J Clin Oncol; 2019 Jul; 24(7):798-806. PubMed ID: 30783810
[TBL] [Abstract][Full Text] [Related]
34. Postoperative Elevations of Neutrophil-to-lymphocyte and Platelet-to-lymphocyte Ratios Predict Postoperative Pulmonary Complications in Non-small Cell Lung Cancer Patients: A Retrospective Cohort Study.
Wang Y; Hu X; Su MC; Wang YW; Che GW
Curr Med Sci; 2020 Apr; 40(2):339-347. PubMed ID: 32337695
[TBL] [Abstract][Full Text] [Related]
35. Pretreatment platelet-to-lymphocyte ratio is associated with the response to first-line chemotherapy and survival in patients with metastatic gastric cancer.
Wang J; Qu J; Li Z; Che X; Liu J; Teng Y; Jin B; Zhao M; Liu Y; Qu X
J Clin Lab Anal; 2018 Jan; 32(1):. PubMed ID: 28238215
[TBL] [Abstract][Full Text] [Related]
36. Systemic Inflammatory Response After Preoperative Chemoradiotherapy Can Affect Oncologic Outcomes in Locally Advanced Rectal Cancer.
Lee IH; Hwang S; Lee SJ; Kang BW; Baek D; Kim HJ; Park SY; Park JS; Choi GS; Kim JC; Cho SH; Kim JG
Anticancer Res; 2017 Mar; 37(3):1459-1465. PubMed ID: 28314318
[TBL] [Abstract][Full Text] [Related]
37. Can preoperative neutrophil:lymphocyte and platelet:lymphocyte ratios be used as predictive markers for lymph node metastasis in squamous cell carcinoma of the vulva?
Ertas IE; Gungorduk K; Akman L; Ozdemir A; Terek MC; Ozsaran A; Sanci M; Dikmen Y
Eur J Obstet Gynecol Reprod Biol; 2013 Nov; 171(1):138-42. PubMed ID: 23992992
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of lymphocyte-to-monocyte ratio and systemic immune-inflammation index in non-small-cell lung cancer patients with brain metastases.
Li A; Mu X; He K; Wang P; Wang D; Liu C; Yu J
Future Oncol; 2020 Oct; 16(30):2433-2444. PubMed ID: 32664750
[No Abstract] [Full Text] [Related]
39. Preoperative Platelet to Albumin Ratio Predicts Outcome of Patients with Non-Small-Cell Lung Cancer.
Guo M; Sun T; Zhao Z; Ming L
Ann Thorac Cardiovasc Surg; 2021 Apr; 27(2):84-90. PubMed ID: 33162436
[TBL] [Abstract][Full Text] [Related]
40. Platelet to lymphocyte ratio as a novel prognostic tool for gallbladder carcinoma.
Pang Q; Zhang LQ; Wang RT; Bi JB; Zhang JY; Qu K; Liu SS; Song SD; Xu XS; Wang ZX; Liu C
World J Gastroenterol; 2015 Jun; 21(21):6675-83. PubMed ID: 26074706
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
